Oakmont, PA, October 06, 2011 --(PR.com
)-- STARR Life Sciences, a leading company in the development and distribution of non-invasive monitoring technology for laboratory research animals, today announced that it was awarded Patent #8,005,624 by the US Patent and Trademark Office. This patent recognizes a number of Starr’s inventions in this field including the use of pulse oximetry on small animals with heart rates at, or in excess of, 450 beats per minute. STARR Life Sciences ’ flagship product, MouseOx®, utilizes this patented technology.
Mike Lang, Chief Executive Officer of STARR Life Sciences, stated, “We are pleased to be awarded this patent formally recognizing our innovations in the field of animal monitoring. STARR has been a pioneer in the area of developing non-invasive methods for monitoring critical parameters in small laboratory research animals. This latest patent provides a critical piece in our intellectual property portfolio.”
STARR first introduced the MouseOx® in calendar year 2006, and since that time, has provided thousands of these devices to researchers around the world. Since 2006, there have been over 100 publications from researchers who have used STARR Life Sciences’ devices and who are concerned with the health of their rodents and the quality of their data.
Prior to the introduction of STARR’s technology, researchers and others who were working with rodents that possess heart rates at, or in excess of 450 beats per minute (e.g., mice), had no effective non-invasive means to obtain the blood oxygenation levels of their subjects. With Starr’s invention of a pulse oximeter for these rodents, researchers finally had a noninvasive tool that could provide accurate blood oxygenation readings, and a new market was created.
For more detail, contact STARR Life Sciences at 866-978-2779 or email@example.com.